Works by Álvarez, Belén Martínez-Lage

Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain.

Published in:

PharmacoEconomics, 2006, p. 49, doi. 10.2165/00019053-200624001-00005

By:

• Shearer, Arran T.;
• Bagust, Adrian;
• Ampudia-Blasco, F. Javier;
• Álvarez, Belén Martínez-Lage;
• Escolano, Isabel Pérez;
• Pari's, Gonzalo

Publication type:

Article